Optimizing the Use of Lenalidomide in Relapsed or Refractory Multiple Myeloma: Consensus Statement
Leukemia - United Kingdom
doi 10.1038/leu.2011.3
Full Text
Open PDFAbstract
Available in full text
Date
February 4, 2011
Authors
Publisher
Springer Science and Business Media LLC